Artemis Medicare Services Adjusts Evaluation Amid Mixed Performance Indicators and Market Challenges

Jun 24 2025 08:39 AM IST
share
Share Via
Artemis Medicare Services has recently adjusted its evaluation, influenced by its financial performance and market position. The company reported five consecutive quarters of positive results, showcasing strong operational efficiency and manageable debt levels, while also facing challenges such as modest sales growth and pledged promoter shares.
Artemis Medicare Services has recently undergone an evaluation adjustment, reflecting changes in its underlying trends and market position. The stock, which operates within the small-cap hospital and healthcare services industry, has shown a mix of performance indicators that have influenced this revision in its score.

In the latest quarter, Artemis Medicare reported positive financial results, marking five consecutive quarters of favorable outcomes. Key metrics include an impressive inventory turnover ratio of 93.88 times and a low debt-equity ratio of 0.35 times, indicating a strong operational efficiency and manageable debt levels. The company also achieved a peak profit after tax of Rs 23.03 crore, contributing to a return on equity of 9.9%, which is considered attractive in relation to its price-to-book value of 4.2.

Despite these strengths, the stock has faced challenges, including a relatively low average return on equity of 8.11%, suggesting room for improvement in profitability. Additionally, the company's net sales growth has been modest at an annual rate of 10.64% over the past five years. The presence of pledged promoter shares, accounting for 44.53%, may also exert pressure on the stock in volatile market conditions.

Overall, the evaluation adjustment for Artemis Medicare Services reflects a nuanced view of its current standing within the market, shaped by both its achievements and ongoing challenges.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News